137 related articles for article (PubMed ID: 8194201)
1. An anti-invasive concentration of the alkyl-lysophospholipid ET-18-OCH3 enhances the motility of embryonal chick heart cells cultured on solid substrate.
van Larebeke NA; Bruyneel EA; Mareel MM
Clin Exp Metastasis; 1994 May; 12(3):255-61. PubMed ID: 8194201
[TBL] [Abstract][Full Text] [Related]
2. Antiinvasive activity of hexadecylphosphocholine in vitro.
Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
[TBL] [Abstract][Full Text] [Related]
3. Role of the host tissue in the anti-invasive activity of the alkyllysophospholipid, ET-18-OCH3, in vitro.
Schallier DC; Bruyneel EA; Storme GA; Mareel MM
Clin Exp Metastasis; 1991; 9(6):579-91. PubMed ID: 1752086
[TBL] [Abstract][Full Text] [Related]
4. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.
Storme GA; Berdel WE; van Blitterswijk WJ; Bruyneel EA; De Bruyne GK; Mareel MM
Cancer Res; 1985 Jan; 45(1):351-7. PubMed ID: 4038380
[TBL] [Abstract][Full Text] [Related]
5. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3.
Mollinedo F; MartÃnez-Dalmau R; Modolell M
Biochem Biophys Res Commun; 1993 Apr; 192(2):603-9. PubMed ID: 8484770
[TBL] [Abstract][Full Text] [Related]
6. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids.
Lu X; Arthur G
Cancer Res; 1992 May; 52(10):2813-7. PubMed ID: 1581895
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization.
Kosano H; Takatani O
Cancer Res; 1989 Jun; 49(11):2868-70. PubMed ID: 2785846
[TBL] [Abstract][Full Text] [Related]
8. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
Samadder P; Arthur G
Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of alkyl lysophospholipid in epithelial cancer cell lines and inhibition of cell growth.
Lu X; Zhou X; Kardash D; Arthur G
Biochem Cell Biol; 1993; 71(3-4):122-6. PubMed ID: 8398069
[TBL] [Abstract][Full Text] [Related]
10. Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines.
Lu X; Arthur G
Cancer Res; 1992 May; 52(10):2806-12. PubMed ID: 1581894
[TBL] [Abstract][Full Text] [Related]
11. Alkyllysophospholipid ET-18-OCH3 acts as an activator of protein kinase C in HL-60 cells.
Heesbeen EC; Verdonck LF; Hermans SW; van Heugten HG; Staal GE; Rijksen G
FEBS Lett; 1991 Sep; 290(1-2):231-4. PubMed ID: 1915882
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O
Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912
[TBL] [Abstract][Full Text] [Related]
13. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
Yamazaki T; Sieber F
Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607
[TBL] [Abstract][Full Text] [Related]
14. Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.
Storch J; Munder PG
Lipids; 1987 Nov; 22(11):813-9. PubMed ID: 3444371
[TBL] [Abstract][Full Text] [Related]
15. Increase of transferrin binding induced by an alkyl-lysophospholipid in breast cancer cells.
Kosano H; Takatani O
J Lipid Mediat; 1990; 2(2):117-21. PubMed ID: 2135668
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
[TBL] [Abstract][Full Text] [Related]
17. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR
Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054
[TBL] [Abstract][Full Text] [Related]
18. Modification of cell surface carbohydrates and invasive behavior by an alkyl lysophospholipid.
Bolscher JG; Schallier DC; van Rooy H; Storme GA; Smets LA
Cancer Res; 1988 Feb; 48(4):977-82. PubMed ID: 3338089
[TBL] [Abstract][Full Text] [Related]
19. Effect of lipid derivatives on invasion in vitro and on surface glycoproteins of three rodent cell types.
Storme GA; Bruyneel EA; Schallier DC; Bolscher JG; Berdel WE; Mareel MM
Lipids; 1987 Nov; 22(11):847-50. PubMed ID: 3444376
[TBL] [Abstract][Full Text] [Related]
20. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
Kosano H; Takatani O
Cancer Res; 1988 Nov; 48(21):6033-6. PubMed ID: 3262419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
